FIRE3_2B | R Documentation |
Kaplan-Meier digitized data from FIRE3, figure 2B (PMID 25088940). A reported sample size of 592 for a primary endpoint of objective_response in colorectal cancer.
FIRE3_2B
A data frame of 592 observations and 3 variables:
time | event time (in months) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (folfiri_bevacizumab, folfiri_cetuximab) | |
Heinemann V, von Weikersthal LF, Decker T, et al. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. Lancet Oncol 2014; 15: 1065–75.
summary(FIRE3_2B)
kmplot(FIRE3_2B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.